Nalaganje...
Comparative effectiveness and safety of empagliflozin on cardiovascular mortality and morbidity in adults with type 2 diabetes
BACKGROUND: Based on a single placebo-controlled randomized clinical trial, empagliflozin is licensed to reduce cardiovascular death in diabetes and comorbid cardiovascular disease. METHODS: We examined the comparative effectiveness of empagliflozin on mortality and cardiovascular morbidity in type...
Shranjeno v:
| izdano v: | Ann Transl Med |
|---|---|
| Main Authors: | , |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
AME Publishing Company
2017
|
| Teme: | |
| Online dostop: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5733315/ https://ncbi.nlm.nih.gov/pubmed/29285488 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.21037/atm.2017.08.43 |
| Oznake: |
Označite
Brez oznak, prvi označite!
|